MedTrace Logo

Virtual Reality Versus Proprioceptive Neuromuscular Facilitation on Postmastectomy Lymphedema

NCT04185181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-12-05

No results posted yet for this study

Summary

This study aimed to compare the therapeutic efficacy of VR and PNF on lymphedema and function in unilateral post-mastectomy lymphedema (UPML) patients. The patients were subdivided into two equal groups, 15 in each. Fifteen patients performed virtual reality-based exercises plus complete decongestive therapy, while the other fifteen patients performed proprioceptive neuromuscular facilitation plus complete decongestive therapy. The volume difference between normal and affected limbs was calculated before and after eight sessions of treatment for both groups by using the circumferential method. And the upper limb function was assessed before and after eight sessions of treatment for both groups by using the Arabic version of the Quick DASH scale.

Conditions

  • Postmastectomy Lymphedema

Interventions

OTHER

virtual reality

wii video game based exercise

OTHER

proprioceptive neuromuscular facilitation

PNF with breathing

OTHER

complete decogestive therapy

pneumatic compression, manual lymph drainage, skin care and home exercise program

Sponsors & Collaborators

  • doaa atef

    lead OTHER

Principal Investigators

  • doaa AA abd-el-wahed, A.lecturer · assistant lecturer at faculty of physical therapy, Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-30
Primary Completion
2019-08-05
Completion
2019-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185181 on ClinicalTrials.gov